22:59 , Nov 30, 2018 |  BioCentury  |  Emerging Company Profile

Afyx: Mucosal drug delivery

Afyx Therapeutics is developing bioadhesive patches for mucosal drug delivery to address diseases that are inadequately treated by topical agents. Diseases affecting topically accessible mucosal sites, such as the buccal mucosa, are difficult to treat...
19:53 , May 12, 2017 |  BC Week In Review  |  Financial News

Dermtreat raises $17.7M in series A

On May 8, mucosal disease company Dermtreat ApS (Copenhagen, Denmark) raised $17.7 million in a series A led by Sofinnova Ventures. Also participating were Novo Seeds, Lundbeckfonden Emerge and undisclosed existing shareholders. Dermtreat’s existing investors...
23:05 , May 8, 2017 |  BC Extra  |  Financial News

Dermtreat's series A round brings in $17.7M

Mucosal disease company Dermtreat ApS (Copenhagen, Denmark) raised $17.7 million in a series A round led by Sofinnova Ventures. Also participating were Novo Seeds, Lundbeckfonden Emerge and existing shareholders including Welfare Tech Invest. Dermtreat CEO...